000 01678 a2200457 4500
005 20250516220253.0
264 0 _c20161024
008 201610s 0 0 eng d
022 _a1579-2021
024 7 _a10.1016/j.endonu.2014.04.007
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRíos, A
245 0 0 _aPrimary thyroid lymphoma.
_h[electronic resource]
260 _bEndocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion
_cNov 2014
300 _a497-9 p.
_bdigital
500 _aPublication Type: Letter
650 0 4 _aAged
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xadministration & dosage
650 0 4 _aChemotherapy, Adjuvant
650 0 4 _aCombined Modality Therapy
650 0 4 _aCyclophosphamide
_xadministration & dosage
650 0 4 _aDoxorubicin
_xadministration & dosage
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aLymphoma, B-Cell, Marginal Zone
_xdiagnosis
650 0 4 _aLymphoma, Large B-Cell, Diffuse
_xdiagnosis
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPrednisone
_xadministration & dosage
650 0 4 _aRadiotherapy, Adjuvant
650 0 4 _aRemission Induction
650 0 4 _aRetrospective Studies
650 0 4 _aThyroid Neoplasms
_xdiagnosis
650 0 4 _aThyroidectomy
650 0 4 _aVincristine
_xadministration & dosage
700 1 _aRodríguez, J M
700 1 _aFebrero, B
700 1 _aParrilla, P
773 0 _tEndocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion
_gvol. 61
_gno. 9
_gp. 497-9
856 4 0 _uhttps://doi.org/10.1016/j.endonu.2014.04.007
_zAvailable from publisher's website
999 _c23924916
_d23924916